A new way to read CT scans may predict which liver surgery patients will develop Life-Threatening failure

NCT ID NCT07727759

First seen Jul 27, 2026 · Last updated Aug 12, 2026 · Updated 4 times

Summary

This study tests whether adding a technique called vascular deformation mapping (VDM) to standard CT scans can better predict liver failure after major liver surgery. Researchers will analyze routine preoperative CT images from over 1,000 adults undergoing removal of at least three liver segments. The goal is to develop a risk score that helps surgeons identify high-risk patients before the operation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Preoperative CT volumetry with hepatic vascular deformation mapping (VDM)
What this could lead to
If successful, this could give surgeons a practical tool to identify high-risk patients before liver surgery, potentially reducing life-threatening liver failure.
What could go wrong
This is an observational study, not a treatment trial. The prediction model may not perform as well in real-world settings or may not improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA, HEPATOCELLULAR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Liver and GIT Hospital, Faculty of Medicine, Minia University

    Minya, Minya Governorate, 61519, Egypt

  • Maadi Armed Forces Medical Compound - Department of Liver and Pancreas Surgery and Liver Transplantation

    Maadi, Egypt

  • National Liver Institute, Menoufia University

    Shibīn al Kawm, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.